Probiox has developed and validated in collaboration with Eurogentec SA a gene expression profiling DNA microarray of 200 genes implicated in the expression and regulation of oxidative stress and related inflammation.
OxyGenes is currently being clinically validated in several reference populations and in physiopathological models linked to oxidative stress: obesity, extracorporal circulation, oral contraception, pancreatis, phenylketonuria, and sport.
OxyGeneTM can be used for the identification of new markers for the monitoring of drugs
and nutraceuticals
|